Our spatial analysis showed that there were significant differences between the ER and LR groups and between the DM and non-DM groups in the density of CD3+ or CD4+ immune cells in all tumor regions, including the TC, IM, combined tumor region, and all three hotspots. This evidence concerns the gene CD4 and neoplasm.